SuPporting medicines management in multimorbidity in Primary caRE: a cluster randomised controlled trial

The Health Research Board - Centre for Primary Care Research (Ireland)0 个研究点目标入组 404 人开始时间: 2016年10月20日最近更新: 2024年9月9日

适应症

试验速览

2017 Protocol article in https://www.ncbi.nlm.nih.gov/pubmed/28764753 protocol 2019 Protocol article in https://www.ncbi.nlm.nih.gov/pubmed/32104779 process evaluation protocol (added 28/02/2020) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/34986166/ (added 06/01/2022) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/36245339/ Process evaluation (added 18/10/2022) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/36385206/ secondary analysis (added 18/11/2022) 2023 Results article in https://doi.org/10.1093/fampra/cmad039 Recruiting general practitioners and older patients with multimorbidity to randomized trials (added 05/04/2023) 2024 Results article in https://pubmed.ncbi.nlm.nih.gov/39190222/ Cost effectiveness (added 02/09/2024)

•Practice inclusion criteria:
•1. Have 300 or more older patients (aged =65 years) on their patient panel (based on the need to identify at least 15 patients per practice who are receiving 15 or more medicines and allowing for refusals)
•2. Use Socrates or Health One as a practice management system
•Patient inclusion crtieria:
•1. Aged 65 years and over
•2. Being prescribed at least 15 regular medications

•Practice exclusion criteria:
•Involved in the development and piloting of the intervention or other concurrent medication quality related studies
•Patient exclusion criteria:
•1. Significant mental or physical illness that would impair their ability to consent and take part in the study
•2. Unable to attend the surgery for medication review (e.g. nursing home residents)
•3. Those involved in another medication study

发起方

The Health Research Board - Centre for Primary Care Research (Ireland)